PROSCA 2024 Satellite Symposium: Professor Athanasios Papatsoris
At PROSCA 2024, Prof Athanasios Papatsoris shares insights on the role and impact of oral ADT in clinical practice, drawing from his first-hand experience and clinical expertise.
Read more
PROSCA 2024 Satellite Symposium: Professor Cosimo De Nunzio
At PROSCA 2024, Prof Cosimo De Nunzio outlines the opportunities that oral ADT provide for prostate cancer patients, particularly patients with cardiovascular risks and lower urinary tract symptoms (LUTS).
Read more
PROSCA 2024 Satellite Symposium: Professor Thomas Zilli
At PROSCA 2024, Prof Thomas Zilli shares insights on the role and impact of oral ADT in clinical practice, alongside his experiences using oral ADT for patients with lower urinary tract symptoms (LUTS) and those with existing cardiovascular comorbidities.
Read more
PROSCA 2024 Satellite Symposium: Professor Amit Bahl
At PROSCA 2024, Prof Amit Bahl discusses the role and impact of oral ADT in the treatment of prostate cancer, including the broader effects on cardiovascular health, bone health and patient lifestyle
Read more
EAU 2024 Satellite Symposium: Doctor Eva Hellmis, Professor Amit Bahl, Professor Romain Mathieu & Andrew Gabriel
During this meeting, Dr Eva Hellmis, Prof Amit Bahl, Prof Romain Mathieu and Andrew Gabriel talk through patient perspectives of ADT
Read more
PROSCA 2023 Satellite Symposium: Professor Matthias Saar
At PROSCA 2023, Prof Matthias Saar presents the Intermittent ADT in the new era of hormonal therapy and highlights the alternative treatment options.
Read more
EAU 2025 Satellite Symposium: Doctor Vérane Achard
At EAU 2025, Dr Vérane Achard shares insights on the impact of ADT for prostate cancer patients with lower urinary tract symptoms (LUTS), drawing from her first-hand experience and clinical expertise.
Watch Video
PROSCA 2023 Satellite Symposium: Professor Nazareno Suardi
At PROSCA 2023, Prof Nazareno Suardi, discusses how to manage ADT when a patient has a cardiovascular risk
Read more
EAU 2025 Satellite Symposium: Doctor Teresa López Fernández
At EAU 2025, Dr Teresa López Fernández shares insights on the importance of assessing cardiovascular risk in prostate cancer patients and highlight the role of ADT in CV risk management.
Watch Video
EAU 2025 Satellite Symposium: Doctor Giuseppe Banna
At EAU 2025, Prof Giuseppe Banna provides an overview of ADT options in prostate cancer, including considerations around GnRH antagonists and agonists.
Watch Video
PROSCA 2023 Satellite Symposium: Professor Alison Birtle
In this Satellite Symposium, Prof Alison Birtle discusses a practical approach of case studies when treating Metastatic Hormone Sensitive Prostate Cancer with Androgen Deprivation Therapy
Read more
On-demand Events: Doctor Tharshini Ramalingam – Prostate Cancer & Cardiovascular Health
Dr Tharshini Ramalingam discusses the importance of assessing cardiovascular risk in prostate cancer patients
Read more
On-demand Events: Professor Alison Birtle – Potential of oral ADT
With supporting evidence from the HERO trial, Prof Alison Birtle, consultant clinical oncologist at the Rosemere Cancer Centre, discusses individualised treatment, regular monitoring, and the importance of therapies that balance survival benefits with quality of life.
Read more
On-demand Events: Professor Anders Bjartell – Testosterone and how to Measure It
Prof Anders Bjartell, a senior consultant at Skåne University Hospital, Malmö, discusses various aspects of testosterone and its significance in prostate cancer treatment.
Read more
On-demand Events: Professor Bertrand Tombal – Intensification and de-escalation in prsotate cancer
Leading urologist Prof Bertrand Tombal, Université Catholique de Louvain, Belgium, gives a presentation to support a more measured approach to treating metastatic hormone sensitive prostate cancer.
Read more
PROSCA 2024: The Next Generation of Clinical Trials
Prof Athanasios Papatsoris, a leading urologist at University of Athens and Sismanoglio Hospital, Greece, takes a deep dive into the next generation of clinical trials.
Read more
PROSCA 2024: Full highlights from the Accord Satellite Symposium
Leading experts in urology, radiation oncology, and medical oncology give a range of clinical opinions on oral ADT. A comprehensive overview of current practices and future options in prostate cancer.
Read more